Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. (Q39605143)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 June 2012
edit
Language Label Description Also known as
English
Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
scientific article published on 8 June 2012

    Statements

    Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit